Piedmont Health Services (PHS) implemented Medication Assisted Treatment (MAT) for Opioid Use Disorder (OUD) in 2016 at one community health center. Through team-based learning, use of evidence-based practices, and innovating a flexible workflow, we have expanded integrated treatment to eight community health centers (and soon to be nine!). PHS’s successful multisite integration of MAT across clinics shows how MAT care can help patient’s flourish and promote healing across multiple domains.
Lisa Corbin, Behavioral Health Consultant, PCOM Lisa Corbin MSW, LCSW, LCAS
Du CX, Shi J, Tetrault JM, Madden LM, Barry DT. Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine. Family Practice, 24;39(2):234-240 (2022).
Rosenberg, H., Grant, J., & Davis, A. K. Acceptance of non-abstinence as an outcome goal for individuals diagnosed with substance use disorders: A narrative review of published research. Journal of Studies on Alcohol and Drugs, 81(4), 405–415 (2020).
Wakeman, S.E., McGovern, S., Kehoe, L., Kane, M.T., Powell, E.A., Casey, S.K., Yacorps, G.M., Irvin, J.R., Rodriguez, W., Regan, S. Predictors of engagement and retention in care at a lowthreshold substance use disorder bridge clinic. Journal of Substance Abuse Treatment, 141:108848 (2022).
Carter, J., Zevin, B. & Lum, P.J. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco. Addict Sci Clin Pract 14, 20 (2019).